Paclitaxel-Induced Src Activation Is Inhibited by Dasatinib Treatment, Independently of Cancer Stem Cell Properties, in a Mouse Model of Ovarian Cancer

Approximately seventy percent of ovarian cancer patients succumb to the disease within the first 5 years of diagnosis, even after successful surgery and effective chemotherapy treatment. A small subset of chemotherapy resistant cancer stem cells (CSCs) cause relapse of ovarian cancers. This study in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kadife, Elif, Chan, Emily, Luwor, Rodney, Kannourakis, George, Findlay, Jock, Ahmed, Nuzhat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406511/
https://www.ncbi.nlm.nih.gov/pubmed/30791462
http://dx.doi.org/10.3390/cancers11020243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406511/
https://www.ncbi.nlm.nih.gov/pubmed/30791462
http://dx.doi.org/10.3390/cancers11020243

Ejemplares similares